1.Endovascular Treatment of Idiopathic Intracranial Hypertension with Stenting of the Transverse Sinus Stenosis.
Shigeru MIYACHI ; Ryo HIRAMATSU ; Hiroyuki OHNISHI ; Kenkichi TAKAHASHI ; Toshihiko KUROIWA
Neurointervention 2018;13(2):138-143
For many years, the pathophysiology of idiopathic intracranial hypertension (IIH) was interpreted as “secondary intracranial hypertension,” and IIH was considered to be caused by brain edema due to obstructive sleep apnea. Another theory proposed cerebrospinal fluid (CSF) absorption impairment due to excessive medication with vitamin A derivatives. Other reports pointed out the importance of obesity, which may cause an impairment of intracranial venous drainage due to elevated right atrial pressure. Patients with medically refractory IIH have traditionally undergone a CSF diversion. Venous outlet impairment on IIH has recently been reported as a causative or contributory cause, and thus focused venoplasty of the stenotic sinus with a stent has emerged as a new treatment strategy. We report the cases of two patients who presented with headache and papilledema with IIH. They successfully underwent stent placement at the stenosis of the transverse sinus and experienced complete resolution of symptoms.
Absorption
;
Atrial Pressure
;
Brain Edema
;
Cerebrospinal Fluid
;
Constriction, Pathologic*
;
Drainage
;
Headache
;
Humans
;
Obesity
;
Papilledema
;
Pseudotumor Cerebri*
;
Sleep Apnea, Obstructive
;
Stents*
;
Vitamin A
2.Usefulness of the Pipeline Embolic Device for Large and Giant Carotid Cavernous Aneurysms.
Shigeru MIYACHI ; Ryo HIRAMATSU ; Hiroyuki OHNISHI ; Ryokichi YAGI ; Toshihiko KUROIWA
Neurointervention 2017;12(2):83-90
PURPOSE: Conventional coil embolization for large carotid cavernous aneurysms (CCAs) has limited utility due to its inability to prevent recurrences and reduce mass effect. Trapping of the parent artery may have a risk of ischemic complications due to intracranial perfusion disorders. We successfully treated 24 patients with large CCAs using a flow diverter (Pipeline™ embolic device: PED), and this report discusses the safety and efficacy of this method. MATERIALS AND METHODS: Twenty four patients (23 females, mean age 71.5 years old) with large CCAs, including 6 giant CCAs, were treated with a PED over three years. Under sufficient dual anti-platelet management, the PED was deployed over the orifice of the aneurysm. Two patients required multiple telescoping stents. Clinical and radiological states were checked with MRI at 1, 3 and 6 months post-surgically. Angiographic follow-up was performed at 6 months. RESULTS: In all patients, PED was appropriately deployed. Stagnation of contrast with eclipse signs was observed post-angiogram in 21 cases. One patient requiring 5 telescoping stents experienced temporary ischemic symptoms. Fourteen patients experienced improvement of ocular motor impairment deficiency, including 6 patients who recovered. Angiograms at 6 months follow-up showed complete occlusion in 63% (12/19) of patients, and MRI showed reduction of aneurysm volume in 89% (17/19) of patients. CONCLUSION: Flow diverters for large CCAs showed promising clinical and radiological efficacy. They can shrink the aneurysm and improve symptoms without sacrificing the parent artery. It will be necessary to summarize the cases and to verify the long-term results.
Aneurysm*
;
Arteries
;
Embolization, Therapeutic
;
Female
;
Follow-Up Studies
;
Humans
;
Magnetic Resonance Imaging
;
Methods
;
Parents
;
Perfusion
;
Recurrence
;
Stents